KRAS G12C inhibitor 11
Modify Date: 2024-01-06 10:19:17
KRAS G12C inhibitor 11 structure
|
Common Name | KRAS G12C inhibitor 11 | ||
|---|---|---|---|---|
| CAS Number | 2158297-63-1 | Molecular Weight | 551.68 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C32H37N7O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of KRAS G12C inhibitor 11KRAS G12C inhibitor 5 is a KRas G12C inhibitor extracted from patent WO2017201161A1, Compound example 147[1]. |
| Name | KRAS G12C inhibitor 5 |
|---|
| Description | KRAS G12C inhibitor 5 is a KRas G12C inhibitor extracted from patent WO2017201161A1, Compound example 147[1]. |
|---|---|
| Related Catalog | |
| Target |
KRas G12C[1] |
| In Vitro | Kirsten Rat Sarcoma 2 Viral Oncogene Homolog (KRas) is a small GTPase and a member of the Ras family of oncogenes. KRas serves a molecular switch cycling between inactive (GDP -bound) and active (GTP -bound) states to transduce upstream cellular signals received from multiple tyrosine kinases to downstream effectors to regulate a wide variety of processes, including cellular proliferation[1]. |
| References |
[1]. John P. Fischer, et al. Kras g12c inhibitors. WO2017201161A1. |
| Molecular Formula | C32H37N7O2 |
|---|---|
| Molecular Weight | 551.68 |